Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Wrocław, Poland.
International Institute of Translational Medicine, Wisznia Mała, Poland.
J Cell Mol Med. 2020 Jul;24(13):7282-7300. doi: 10.1111/jcmm.15294. Epub 2020 Jun 4.
Chronic osteomyelitis, a bone infectious disease, is characterized by dysregulation of bone homeostasis, which results in excessive bone resorption. Lipopolysaccharide (LPS) which is a gram-negative endotoxin was shown to inhibit osteoblast differentiation and to induce apoptosis and osteoclasts formation in vitro. While effective therapy against bacteria-induced bone destruction is quite limited, the investigation of potential drugs that restore down-regulated osteoblast function remains a major goal in the prevention of bone destruction in infective bone diseases. This investigation aimed to rescue LPS-induced MC3T3-E1 pre-osteoblastic cell line using the methanolic extract of Cladophora glomerata enriched with Mn(II) ions by biosorption. LPS-induced MC3T3-E1 cultures supplemented with C. glomerata methanolic extract were tested for expression of the main genes and microRNAs involved in the osteogenesis pathway using RT-PCR. Moreover, osteoclastogenesis of 4B12 cells was also investigated by tartrate-resistant acid phosphatase (TRAP) assay. Treatment with algal extract significantly restored LPS-suppressed bone mineralization and the mRNA expression levels of osteoblast-specific genes such as runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteocalcin (OCN), osteopontin (OPN), miR-27a and miR-29b. The extract also inhibited osteoblast apoptosis, significantly restored the down-regulated expression of Bcl-2, and decreased the loss of MMP and reactive oxygen spices (ROS) production in MC3T3-E1 cells induced by LPS. Furthermore, pre-treatment with algal extract strongly decreased the activation of osteoclast in MC3T3-E1-4B12 coculture system stimulated by LPS. Our findings suggest that C. glomerata enriched with Mn(II) ions may be a potential raw material for the development of drug for preventing abnormal bone loss induced by LPS in bacteria-induced bone osteomyelitis.
慢性骨髓炎是一种骨感染性疾病,其特征为骨稳态失调,导致过度的骨吸收。脂多糖(LPS)作为革兰氏阴性内毒素,已被证明可抑制成骨细胞分化,并在体外诱导成骨细胞凋亡和破骨细胞形成。虽然针对细菌诱导的骨破坏的有效治疗方法相当有限,但研究潜在的药物以恢复下调的成骨细胞功能仍然是预防感染性骨病中骨破坏的主要目标。本研究旨在通过生物吸附用富含 Mn(II) 离子的石莼甲醇提取物来挽救 LPS 诱导的 MC3T3-E1 前成骨细胞系。用 LPS 诱导的 MC3T3-E1 培养物,用 C. glomerata 甲醇提取物进行补充,并用 RT-PCR 检测参与成骨途径的主要基因和 microRNAs 的表达。此外,还通过抗酒石酸酸性磷酸酶(TRAP)测定法研究 4B12 细胞的破骨细胞生成。用藻类提取物处理可显著恢复 LPS 抑制的骨矿化以及成骨细胞特异性基因如 runt 相关转录因子 2(Runx2)、碱性磷酸酶(ALP)和骨钙素(OCN)、骨桥蛋白(OPN)、miR-27a 和 miR-29b 的 mRNA 表达水平。该提取物还抑制成骨细胞凋亡,显著恢复 LPS 下调的 Bcl-2 表达,并减少 LPS 诱导的 MC3T3-E1 细胞中 MMP 和活性氧物质(ROS)产生的损失。此外,藻类提取物预处理强烈降低了 LPS 刺激的 MC3T3-E1-4B12 共培养系统中破骨细胞的激活。我们的研究结果表明,富含 Mn(II) 离子的石莼可能是一种有潜力的原料,可用于开发预防 LPS 诱导的细菌诱导性骨髓炎中异常骨质流失的药物。